Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2020 1
2021 4
2023 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Paton NI, Cousins C, Suresh C, Burhan E, Chew KL, Dalay VB, Lu Q, Kusmiati T, Balanag VM, Lee SL, Ruslami R, Pokharkar Y, Djaharuddin I, Sugiri JJR, Veto RS, Sekaggya-Wiltshire C, Avihingsanon A, Sarin R, Papineni P, Nunn AJ, Crook AM; TRUNCATE-TB Trial Team. Paton NI, et al. N Engl J Med. 2023 Mar 9;388(10):873-887. doi: 10.1056/NEJMoa2212537. Epub 2023 Feb 20. N Engl J Med. 2023. PMID: 36808186 Free PMC article. Clinical Trial.
Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial.
Paton NI, Cousins C, Sari IP, Burhan E, Ng NK, Dalay VB, Suresh C, Kusmiati T, Chew KL, Balanag VM, Lu Q, Ruslami R, Djaharuddin I, Sugiri JJR, Veto RS, Sekaggya-Wiltshire C, Avihingsanon A, Saini JK, Papineni P, Nunn AJ, Crook AM; TRUNCATE-TB Trial Team. Paton NI, et al. Lancet Infect Dis. 2025 Oct;25(10):1084-1096. doi: 10.1016/S1473-3099(25)00151-3. Epub 2025 May 22. Lancet Infect Dis. 2025. PMID: 40414233 Free PMC article. Clinical Trial.
Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis.
Eckold C, Kumar V, Weiner J, Alisjahbana B, Riza AL, Ronacher K, Coronel J, Kerry-Barnard S, Malherbe ST, Kleynhans L, Stanley K, Ruslami R, Ioana M, Ugarte-Gil C, Walzl G, van Crevel R, Wijmenga C, Critchley JA, Dockrell HM, Cliff JM; TANDEM consortium. Eckold C, et al. Clin Infect Dis. 2021 Jan 23;72(1):69-78. doi: 10.1093/cid/ciaa751. Clin Infect Dis. 2021. PMID: 32533832 Free PMC article.
Anti-inflammatory activity of 2-((3-(chloromethyl)benzoyl)oxy)benzoic acid in LPS-induced rat model.
Tjahjono Y, Karnati S, Foe K, Anggara E, Gunawan YN, Wijaya H, Steven, Suyono H, Esar SY, Hadinugroho W, Wihadmadyatami H, Ergün S, Widharna RM, Caroline. Tjahjono Y, et al. Among authors: gunawan yn. Prostaglandins Other Lipid Mediat. 2021 Jun;154:106549. doi: 10.1016/j.prostaglandins.2021.106549. Epub 2021 Apr 5. Prostaglandins Other Lipid Mediat. 2021. PMID: 33831580
The effect of a structured clinical algorithm on glycemic control in patients with combined tuberculosis and diabetes in Indonesia: A randomized trial.
Ruslami R, Koesoemadinata RC, Soetedjo NNM, Imaculata S, Gunawan Y, Permana H, Santoso P, Alisjahbana B, McAllister SM, Grint D, Critchley JA, Hill PC, van Crevel R. Ruslami R, et al. Among authors: gunawan y. Diabetes Res Clin Pract. 2021 Mar;173:108701. doi: 10.1016/j.diabres.2021.108701. Epub 2021 Feb 18. Diabetes Res Clin Pract. 2021. PMID: 33609618 Clinical Trial.
12 results